These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 10052204)
1. [EURO-Medicines: a European program for bringing into agreement public health policies on drugs]. Calamo-Specchia F; Bucci R; Folino-Gallo P Ann Ig; 1998; 10(5-6):405-12. PubMed ID: 10052204 [No Abstract] [Full Text] [Related]
2. Orphan drug development across Europe: bottlenecks and opportunities. Heemstra HE; de Vrueh RL; van Weely S; Büller HA; Leufkens HG Drug Discov Today; 2008 Aug; 13(15-16):670-6. PubMed ID: 18583178 [TBL] [Abstract][Full Text] [Related]
3. [The Medical Products Agency's preparations prior to the new EU regulation on children and drugs]. Johannesson M; Berglund EG Lakartidningen; 2007 Jul 11-24; 104(28-29):2099. PubMed ID: 17702388 [No Abstract] [Full Text] [Related]
4. [Is it possible (and desirable) to administer a standard for an effective health policy for the European Union?]. Bruch M Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(2):5-10. PubMed ID: 9534267 [TBL] [Abstract][Full Text] [Related]
5. [European drug policy]. Sauer F Bull Mem Acad R Med Belg; 1993; 148(5-6):207-12; discussion 212-6. PubMed ID: 8142930 [TBL] [Abstract][Full Text] [Related]
6. Policy benchmarking report on neonatal health and social policies in 13 European countries. Keller M; Felderhoff-Mueser U; Lagercrantz H; Dammann O; Marlow N; Hüppi P; Buonocore G; Poets C; Simbruner G; Guimaraes H; Mader S; Merialdi M; Saugstad OD Acta Paediatr; 2010 Nov; 99(11):1624-9. PubMed ID: 20500729 [TBL] [Abstract][Full Text] [Related]
7. Future European health care: cost containment, health care reform and scientific progress in drug research. Emilien G Int J Health Plann Manage; 1997; 12(2):81-101. PubMed ID: 10173136 [TBL] [Abstract][Full Text] [Related]
8. The Stockholm Manifesto. Creating a safe environment for children in Europe. Vincenten J; Int J Inj Contr Saf Promot; 2005 Jun; 12(2):123-7. PubMed ID: 16156538 [TBL] [Abstract][Full Text] [Related]
9. Evaluating and improving orphan drug regulations in Europe: a Delphi policy study. Picavet E; Cassiman D; Simoens S Health Policy; 2012 Nov; 108(1):1-9. PubMed ID: 22989856 [TBL] [Abstract][Full Text] [Related]
10. [European registration of medicines: pros and cons for prescriber and patient]. Offerhaus L Ned Tijdschr Geneeskd; 1997 May; 141(21):1028-33. PubMed ID: 9340558 [TBL] [Abstract][Full Text] [Related]
12. Future of the European Union regulatory network in the context of the uptake of new medicines. Hoebert JM; Irs A; Mantel-Teeuwisse AK; Leufkens HG Br J Clin Pharmacol; 2013 Jul; 76(1):1-6. PubMed ID: 23043328 [No Abstract] [Full Text] [Related]
13. [1992: pills without limits?]. Offerhaus L Ned Tijdschr Geneeskd; 1990 Apr; 134(16):821-7. PubMed ID: 2336124 [No Abstract] [Full Text] [Related]
15. EU consensus lacking on needle exchange. Alcorn K J Int Assoc Physicians AIDS Care; 1998 Jun; 4(6):37. PubMed ID: 11365534 [TBL] [Abstract][Full Text] [Related]
16. Hiding behind agency discretion: the Food and Drug Administration's personal use drug importation policy. Reichertz PS; Friend MS Cornell J Law Public Policy; 2000; 9():493-521. PubMed ID: 11067734 [No Abstract] [Full Text] [Related]
17. Multi-level governance: The way forward for European illicit drug policy? Chatwin C Int J Drug Policy; 2007 Dec; 18(6):494-502. PubMed ID: 18061875 [TBL] [Abstract][Full Text] [Related]
18. The European Research and Technological Development Programmes concerning food, nutrition and health. Bochereau L; Breslin L Br J Nutr; 1999 Feb; 81(2):113-4. PubMed ID: 10450328 [No Abstract] [Full Text] [Related]
19. [Registration of new medicinal products in Europe]. Singer E Onkologie; 2008; 31 Suppl 2():64-6. PubMed ID: 18487872 [TBL] [Abstract][Full Text] [Related]